UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007913 |
|---|---|
| Receipt number | R000009310 |
| Scientific Title | HLA-mismatched allogeneic hematopoietic stem cell transplantation for advanced hematological malignancy using low-dose alemtuzumab |
| Date of disclosure of the study information | 2012/06/01 |
| Last modified on | 2019/11/15 00:11:18 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/05/09 04:15:11 | ||
| 2 | Update | 2012/05/13 15:09:41 | Interventions/Control_1 Key inclusion criteria |
|
| 3 | Update | 2012/05/13 15:11:17 | Organization Organization |
|
| 4 | Update | 2012/11/09 23:33:03 | ||
| 5 | Update | 2015/05/09 18:41:50 | Recruitment status |
|
| 6 | Update | 2015/05/09 18:43:12 | TEL Address Address TEL |
|
| 7 | Update | 2016/05/10 00:50:18 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 8 | Update | 2016/05/10 00:51:14 | Publication of results |
|
| 9 | Update | 2019/11/14 22:54:08 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Zip code Address TEL Organization Organization Address Address Tel |
|
| 10 | Update | 2019/11/14 23:00:04 | Recruitment status Date of IRB Last follow-up date |
|
| 11 | Update | 2019/11/15 00:11:18 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
